| ||
| ||
| ||
| ||
| ||
Antibody Development & Production Wrap Up
The Antibody Development & Production Event took place on March 12-14 at the beautiful Sheraton San Diego Hotel & Marina in San Diego, CA and welcomed over 300 attendees to learn from the most respected industry scientists, engineers and executives for 3 full days of presentations, panel discussions, technology workshops and numerous networking opportunities. Regarded as the bioprocessing industry's premier single-track event, attendees experienced best practices and case studies from all the critical stages of upstream and downstream processing.
Highlights during the Visionaries in Antibody Manufacturing Plenary Session included a proposal from Dr. Wolfgang Noe of Biogen Idec for the industry to implement standardizing metrics when benchmarking process development and Dr. Rolf Werner's discussion on the next generation of immunotherapeutics, including antibody conjugates, antibody fragments and protein scaffolds. During the Eye Toward the Future Plenary Session the following evening, William R. Strohl of Merck Research Laboratories described what therapeutic antibodies will look like in the future and Greg Blank of Genentech examined the role of chromatography in the mAb processes of tomorrow.
The exhibit hall was open for two days and networking abounded as evidenced by the heavy traffic in every isle during the refreshment breaks, luncheons and cocktail reception.
Please call Customer Service at 800-390-4078 if you would like to purchase a copy of the handbook from our 2008 event.
Copyright IBC Life Sciences, a part of Informa Life Sciences Group